BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 1470582)

  • 1. [Beta 2-microglobulin--its role in renal failure and hemodialysis therapy].
    Czyz W; Szepietowski T
    Postepy Hig Med Dosw; 1992; 46(2):209-38. PubMed ID: 1470582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum beta 2-microglobulin concentration in dialysis patients: importance of intrinsic renal function.
    McCarthy JT; Williams AW; Johnson WJ
    J Lab Clin Med; 1994 Apr; 123(4):495-505. PubMed ID: 8144998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Amyloidosis associated with chronic hemodialysis. The prognostic significance of beta 2-microglobulin changes in patients with terminal chronic kidney failure treated by repeated hemodialysis].
    Manasia M; Meseşan M; Gherman-Căprioară M; Malide D; Paţiu IM; Pârvu L; Vlăduţiu D; Spânu CS
    Med Interna; 1991; 43(1-2):129-34. PubMed ID: 1670118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Beta-2 microglobulin and amyloid osteoarthropathy in patients undergoing chronic hemodialysis].
    Prinseau J; Baglin A; Benoit J; Leparc JM; Got C; Louis MF; Attar B; Fritel D
    Ann Med Interne (Paris); 1989; 140(2):94-8. PubMed ID: 2662855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta 2-microglobulin associated amyloidosis and therapy with high flux hemodialysis membranes.
    Floege J; Koch KM
    Clin Nephrol; 1994 Jul; 42 Suppl 1():S52-6. PubMed ID: 7923985
    [No Abstract]   [Full Text] [Related]  

  • 6. beta 2-microglobulin and amyloidosis: who is at risk?
    Davison AM
    Nephrol Dial Transplant; 1995; 10 Suppl 10():48-51. PubMed ID: 8825433
    [No Abstract]   [Full Text] [Related]  

  • 7. New aspects in the pathogenesis of dialysis-related amyloidosis: pathophysiology of advanced glycation end products in renal failure.
    Miyata T
    Nihon Jinzo Gakkai Shi; 1996 May; 38(5):191-7. PubMed ID: 8699608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Beta 2-microglobulin-induced amyloidosis. A new complication of long-term hemodialysis].
    Ritz E; Bommer J; Zeier M
    Dtsch Med Wochenschr; 1988 Feb; 113(5):190-6. PubMed ID: 3276494
    [No Abstract]   [Full Text] [Related]  

  • 9. [Amyloidosis of the dialysis patient].
    van Ypersele de Strihou C
    Bull Mem Acad R Med Belg; 1988; 143(10-12):456-65; discussion 465-7. PubMed ID: 3077074
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of hollow-fiber dialyzer Plivadial Altra-Flux 140 on beta-2-microglobulin removal.
    Kes P; Zubcić A; Ratković-Gusić I; Prsa M; Sefer S
    Acta Med Croatica; 1997; 51(2):105-9. PubMed ID: 9204596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta 2-microglobulin amyloidosis: why and how to look for it.
    Schaeffer J; Ehlerding G; Flöge J; Koch KM; Shaldon S
    Clin Nephrol; 1995 Nov; 44 Suppl 1():S3-9. PubMed ID: 8608659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dialysis amyloidosis and beta-2-microglobulin].
    Sulková S; Votruba T
    Cas Lek Cesk; 1989 Jan; 128(3):68-73. PubMed ID: 2655913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastrointestinal involvement of dialysis-related amyloidosis.
    Takahashi S; Morita T; Koda Y; Murayama H; Hirasawa Y
    Clin Nephrol; 1988 Sep; 30(3):168-71. PubMed ID: 3052956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study.
    Traut M; Haufe CC; Eismann U; Deppisch RM; Stein G; Wolf G
    Blood Purif; 2007; 25(5-6):432-40. PubMed ID: 17957097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Significance of serum levels of beta-2-microglobulin in dialysis patients].
    Baldrati L; Baldrati L; Delvecchio C; Capponcini C; Docci D; Turci F; Feletti C
    Recenti Prog Med; 1990 Sep; 81(9):561-3. PubMed ID: 2263750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of novel beta 2-microglobulin in the serum of hemodialysis patients and its amyloidogenic predisposition.
    Ogawa H; Saito A; Oda O; Nakajima M; Chung TG
    Clin Nephrol; 1988 Sep; 30(3):158-63. PubMed ID: 3052955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta2-microglobulin amyloidosis in hemodialysis and peritoneal dialysis patients.
    Dervisoglu E; Anik Y; Erdogan S; Akansel G; Yilmaz A
    Ther Apher Dial; 2008 Aug; 12(4):306-10. PubMed ID: 18789118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloidosis and its impact on patients with ESRD.
    Copeland SD
    Nephrol Nurs J; 2006; 33(1):31-3; quiz 34-5. PubMed ID: 16538926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The analysis of plasma beta 2-microglobulin concentration in patients with chronic renal failure treated by hemodialysis].
    Król Z; Morawska Z
    Pediatr Pol; 1996 Feb; 71(2):121-5. PubMed ID: 8966077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Changes in the beta 2-microglobulin level during hemodialysis].
    Nikitinskaia LP; Stetsiuk EA; Iarmolinskiĭ IS; Barinov AV; Kon'kova TA
    Urol Nefrol (Mosk); 1990; (5):29-31. PubMed ID: 2264202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.